https://www.selleckchem.com/pr....oducts/blasticidin-s
00, 95% CI 0.91-1.1. Among EXSCEL participants, enrollment in Latin America (HR 0.51, 95% CI 0.43-0.6 and a history of peripheral artery disease (HR 0.79, 95% CI 0.70-0.9 were associated with a reduced risk for coronary revascularization, whereas enrollment in North America (HR 1.92, 95% CI 1.74-2.12), a history of CV disease (HR 3.24, 95% CI 2.78-3.78), and a previous myocardial infarction (HR 1.54, 95% CI 1.39-1.71) were associated with increased risk for study end points. EQW had no association with hospitalization fo
Мне нравится
Комментарий
Перепост
